SCLC-22HHomo sapiens (Human)Cancer cell line

Also known as: SCLC22H

🤖 AI SummaryBased on 7 publications

Quick Overview

Human small cell lung cancer cell line with known genetic and molecular characteristics.

Detailed Summary

SCLC-22H is a human small cell lung cancer cell line derived from a pleural effusion. It is characterized by the expression of neuroendocrine markers such as L-DOPA decarboxylase (DDC), neuron-specific enolase (NSE), and creatine kinase (CK), including its BB isoenzyme. The cell line exhibits high levels of DDC activity and CK-BB, which are indicative of its neuroendocrine differentiation. SCLC-22H has been used in studies investigating the biological properties of small cell lung cancer, including its growth characteristics, response to therapies, and chromosomal abnormalities. It is also noted for its ability to form colonies in soft agar, indicating its tumorigenic potential. The cell line has been shown to have a near-diploid DNA content and specific chromosomal deletions, such as those involving chromosome 3p, which are common in small cell lung cancer. Additionally, SCLC-22H has been utilized in research related to the expression of galectins and viral sequences, contributing to the understanding of cancer immunology and tumor biology.

Research Applications

Neuroendocrine marker expression analysisGenomic and chromosomal characterizationDrug sensitivity and resistance studiesTumor biology and metastasis researchImmunological studies of cancer cell lines

Key Characteristics

Expression of DDC, NSE, and CK-BBNear-diploid DNA contentChromosomal deletions on 3pAbility to form colonies in soft agarHigh DDC activity and CK-BB levels
Generated on 6/18/2025

Basic Information

Database IDCVCL_2186
SpeciesHomo sapiens (Human)
Tissue SourcePericardial effusion[UBERON:UBERON_0002409]

Donor Information

Age46
Age CategoryAdult
SexMale
Racecaucasian

Disease Information

DiseaseSmall cell lung cancer
LineageLung
SubtypeSmall Cell Lung Cancer
OncoTree CodeSCLC

DepMap Information

Source TypeDSMZ
Source IDACH-001386_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Pro278Arg (c.833C>G)Homozygous-Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
10
D13S317
12
D16S539
12
D18S51
14,15
D19S433
13,14
D21S11
29,31.2
D2S1338
17,20
D3S1358
15
D5S818
11,12
D7S820
11
D8S1179
12,13
FGA
22
Penta D
9
Penta E
12,13
TH01
9.3
TPOX
8,9
vWA
17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.

Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.

OncoImmunology 3:e954893.1-e954893.12(2014).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.

Wolf E., Gabius H.-J.

J. Cancer Res. Clin. Oncol. 127:375-386(2001).

Establishment, growth properties, and morphological characteristics of permanent human small cell lung cancer cell lines.

Bepler G., Jaques G., Neumann K., Aumuller G., Gropp C., Havemann K.

J. Cancer Res. Clin. Oncol. 113:31-40(1987).

Spontaneous changes in intermediate filament protein expression patterns in lung cancer cell lines.

Carney D.N., Vooijs G.P., Ramaekers F.C.S.

J. Cell Sci. 91:91-108(1988).

Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.

Bepler G., Jaques G., Koehler A., Gropp C., Havemann K.

J. Cancer Res. Clin. Oncol. 113:253-259(1987).

Novel antigens characteristic of neuroendocrine malignancies.";

Boerman O.C., Ramaekers F.C.S.

Cancer 67:619-633(1991).

Expression of the vasopressin and gastrin-releasing peptide genes in small cell lung carcinoma cell lines.

Burbach J.P.H.

Pathobiology 60:136-142(1992).